Executive Brief

  • Labcorp Holdings Inc. announced it will release Q3 2025 financial results on October 28, 2025, before market open, with a conference call and webcast at 9 a.m. ET (Item 7.01, Exhibit 99.1).
  • The webcast and dial-in for the earnings call will be listen-only; a replay will be available until October 15, 2026 (Item 7.01, Exhibit 99.1).
  • No new financial guidance, operational updates, or material agreements disclosed in this filing; purely an earnings announcement schedule (Item 7.01).
  • The press release reiterates Labcorp’s global leadership in laboratory services, with ~70,000 employees, operations in ~100 countries, and support for 75% of new FDA-approved drugs in 2024 (Exhibit 99.1).
  • No other Items such as financial statements, director changes, or material agreements were reported (Item 9.01 only references the press release).
  • No forward-looking statements or risk factors explicitly included in this filing.
  • No changes to governance, auditor, or securities reported.
  • No dilution, M&A, or impairment information disclosed.
  • The filing is routine and previously unannounced information about the earnings release date and call logistics.
  • Investors should monitor the October 28 earnings release for substantive financial and operational updates.

Item-by-Item Analysis

Item 7.01 – Regulation FD Disclosure

  • What happened: Labcorp announced the date and details for its Q3 2025 earnings release and conference call.
  • Parties/terms: Earnings release scheduled before market open on October 28, 2025; conference call and webcast at 9 a.m. ET same day; listen-only format; replay available until October 15, 2026.
  • Conditions/closing: None stated.
  • Source: (Item 7.01, para 1-6), (Exhibit 99.1).

Item 9.01 – Financial Statements and Exhibits

  • What happened: The press release dated September 25, 2025, announcing the earnings release schedule is furnished as Exhibit 99.1.
  • Source: (Item 9.01), (Exhibit 99.1).

Exhibits Summary

  • Exhibit 99.1: Press release dated September 25, 2025, announcing Q3 2025 earnings release date and call details; includes company overview and webcast logistics.
  • Exhibit 104: Inline XBRL cover page (standard).

Financial & Dilution Impact

  • None disclosed in this filing.

Timeline & Required Actions

  • October 28, 2025: Q3 2025 earnings release before market open.
  • October 28, 2025, 9 a.m. ET: Conference call and webcast.
  • Replay available until October 15, 2026.

Risks & Monitoring

  • No new risks or uncertainties disclosed.
  • Monitor October 28 earnings release for material financial and operational updates.

Metadata & Quality Checks

  • No OCR or parsing issues noted.
  • Non-GAAP reconciliation: Unknown (not referenced).
  • Forward-looking statements: No explicit statements included.
  • Related-party transactions: None disclosed.

Final Checklist

  • Items present: 7.01, 9.01
  • Items absent: 1.01, 2.02, 2.03, 2.06, 3.01, 3.02, 4.01, 4.02, 5.02, 5.03, 5.07, 8.01
  • Press release included as Exhibit 99.1
  • No material agreements or financial data disclosed
  • Routine earnings announcement filing only

Original Filing